June 26 (Reuters) - Cleo Diagnostics Ltd (COV) :
- COMMENCES U.S. REGULATORY PROCESS WITH FDA
- COMPLETED AN INITIAL PRE-SUBMISSION MEETING WITH FDA
- OUTLINED ITS SUBMISSION FRAMEWORK AND CLINICAL PLAN FOR ITS OVARIAN CANCER DETECTION BLOOD TEST WITH FDA
(([email protected];))
- Forums
- ASX - By Stock
- COV
- News: COV Cleo Diagnostics Commences U.S. Regulatory Process With FDA
News: COV Cleo Diagnostics Commences U.S. Regulatory Process With FDA
Featured News
Add COV (ASX) to my watchlist
|
|||||
Last
32.0¢ |
Change
-0.015(4.48%) |
Mkt cap ! $26.11M |
Open | High | Low | Value | Volume |
32.5¢ | 32.5¢ | 31.0¢ | $70.84K | 222.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 29329 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.315 |
3 | 19128 | 0.310 |
3 | 41569 | 0.305 |
5 | 68249 | 0.300 |
1 | 26685 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 29329 | 2 |
0.370 | 26664 | 1 |
0.380 | 20212 | 1 |
0.390 | 27129 | 1 |
0.395 | 15000 | 1 |
Last trade - 15.00pm 22/07/2024 (20 minute delay) ? |
Featured News
COV (ASX) Chart |